Variation in axillary node dissection influences the degree of nodal involvement in breast cancer patients

Journal of Surgical Oncology

Volumn 73, Issue 3, 2000, Pages 134-137

  Saha, Sanjoy ^a   Farrar, William B ^a   Young, Donn C ^b   Ferrara, John J ^c   Burak Jr , William E ^a,d  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d NONE   (United States)

Author keywords

Axillary dissection; Axillary level; Breast cancer; Lymph nodes; Metastasis

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER SURGERY; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

AXILLA; BIAS (EPIDEMIOLOGY); BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS;

EID: 0034104962     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(200003)73:3<134::AID-JSO4>3.0.CO;2-F     Document Type: Article

References (19)

1. Ruffin WK, Stacey-Clear A, Younger J, et al.: Rationale for routine axillary dissection in carcinoma of breast. J Am Coll Surg 1995;180:245-251.
2. Fisher B, Bauer M, Wickerham DL, et al.: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: An NSABP update. Cancer 1983;52:1551-1557.
3. Hurd DD, Peters WP: Randomized comparative study of high dose (with autologous bone marrow support) versus low-dose cyclophosphamide, cisplatin, and carmustine as consolidation to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for patients with operable stage I or II breast cancer involving 10 or more axillary lymph nodes (CALBG protocol 9082). Cancer and Leukemia Group B. J Natl Cancer Inst Monogr 1995:19:41-44.
4. National Comprehensive Cancer Network: Update of the NCCN guidelines for treatment of breast cancer. Oncology 1997;11:199-222.
5. International (Ludwig) Breast Cancer Study Group: Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990;335:1565-1568.
6. Morrow M: Axillary dissection: When and how radical. Semin Surg Oncol 1996;12:321-327.
7. Recht A, Houlihan MJ: Axillary lymph nodes and breast cancer: A review. Cancer 1995;76:1491-1512.
8. Burak WE Jr, Goodman PS, Young DC, et al.: Seroma formation following axillary dissection for breast cancer: Risk factors and lack of influence of bovine thrombin. Surg Oncol 1997;64:27-31.
9. Chevinsky A, Ferrara J, James A, et al.: Prospective evaluation of clinical and pathologic detection of axillary metastases in patients with carcinoma of the breast. Surgery 1990;108:612-618.
10. Van Lancker M, Goor C, Sacre R, et al.: Pattern of axillary lymph node metastasis in breast cancer. Am J Clin Oncol 1995;18:267-272.
11. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992;339:1-15, 71-85.
12. Perloff M, Norton L, Korzun AH, et al.: Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: A Cancer and Leukemia Group B study. J Clin Oncol 1994;14:1589-1598.
13. Axelsson C, Mouridsen H, Zedeler K, et al.: Axillary dissection of level I and II lymph nodes is important in breast cancer classification [abstract]. Eur J Cancer 1992;28A:1450.
14. Rosen P, Martin M, Kinne D, et al.: Discontinuous or skip metastases in breast carcinoma: Analysis of 1228 axillary dissection. Ann Surg 1983;197:276-283.
15. Veronesi U, Rilke F, Luini A, et al.: Distribution of axillary node metastases by level of invasion. Cancer 1987;59: 682.
16. Pigott J, Nichols R, Maddox W, et al.: Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures. Surg Gynecol Obstet 1984;158:255.
17. Boova R, Bonanni R, Rosato F: Patterns of axillary node involvement in breast cancer. Ann Surg 1982;196:642-644.
18. Guiliano AE, Kirgan DM, Guenther JM, et al.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
19. Guiliano AE: Sentinel lymphadenectomy in primary breast carcinoma: An alternative to routine axillary dissection. J Surg Oncol 1996;62:75-77.